Timothy Marlowe

Dr. Marlowe is Chief Scientific Officer and leads the research & development efforts at FAKnostics, LLC. He is also an Assistant Professor at the University of Arizona College of Medicine–Phoenix and University of Arizona College of Pharmacy, specializing in high-throughput screening, medicinal chemistry, cancer biology, and drug development. Dr. Marlowe is the inventor of the FAK peptide technology (WO2021042064A1) and directs the research and development of the FAK inhibitor. Dr. Marlowe helped raise $2.3M in funds to develop the FAK inhibitor for FDA IND approval. He has an extensive background in drug discovery and pharmacology, with major expertise in structure-based drug design, computational drug discovery, and a wide-variety of biophysical/biochemical assays. He received his PhD from the Roswell Park Cancer Institute in Molecular Pharmacology and Cancer Therapeutics, and his BS from the University at Buffalo in Pharmacology and Toxicology.